Overview
PHASE ONE, TWO COUNTRIES, THREE CLINICS
Nucleus Network is Australia’s largest Phase 1 clinical research organization and the only clinical pharmacology specialist globally with facilities in the USA and Australia.
For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including China, Europe, Japan, South Korea, Taiwan and the USA.
Recognized as Phase 1 clinical trial experts, having overseen over 1,000 trials across our three sites, in Melbourne and Brisbane (Australia) and Minneapolis (USA), we are Australia’s premier Phase 1 trial facility and one of the very few specialized units capable of delivering patients for hepatic and renal clinical trials in the USA.
Operating over 200 dedicated beds combined, our three sites in Australia (Melbourne and Brisbane) and the USA (Minneapolis) are co-located in world-leading medical research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, and Medical Alley in Minnesota.
These precincts provide our internationally recognized, in-house Principal Investigators and scientists with unique access to highly specialized ancillary services for the conduct of complex Phase 1 clinical trials.
From specialist PD equipment for first in human studies in Melbourne, purpose-built infrastructure for high volume biosimilar studies in Brisbane, and on-site dialysis capabilities for complicated renal studies in Minneapolis, Nucleus Network has the experience to conduct the most complex early phase clinical trials.
Australia is becoming the clinical trial destination of choice for several compelling reasons.
1. Speed – you can have first-patient-in in around 7-8 weeks and do not need an IND to commence
2. Quality – data generated is accepted by FDA and EMA
3. Cost – the Australian R&D tax incentive offers up to 43.5% cash rebate for work performed there
Together with our clients, we are fulfilling our purpose of “Advancing medicine, improving lives.”
Please contact Jeffrey Wong – Director of Business Development – j.wong@nucleusnetwork.com.au.